No abstract available
Keywords:
Dabigatran; Hemorrhagic transformation; Idarucizumab; Ischemic stroke; Thrombolysis.
MeSH terms
-
Aged
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antithrombins / adverse effects*
-
Antithrombins / therapeutic use
-
Brain Ischemia / diagnostic imaging
-
Brain Ischemia / drug therapy
-
Dabigatran / adverse effects*
-
Dabigatran / therapeutic use
-
Fatal Outcome
-
Female
-
Humans
-
Intracranial Hemorrhages / diagnostic imaging
-
Intracranial Hemorrhages / etiology*
-
Intracranial Hemorrhages / therapy
-
Male
-
Middle Aged
-
Stroke / diagnostic imaging
-
Stroke / drug therapy*
-
Thrombolytic Therapy / adverse effects*
Substances
-
Antibodies, Monoclonal, Humanized
-
Antithrombins
-
idarucizumab
-
Dabigatran